Deferred Revenue

12 Months Ended

Dec. 31, 2014

Deferred Revenue Disclosure [Abstract]

Deferred Revenue

Deferred Revenue

Deferred revenue consists of the following:

	As of December 31,
	2014		2013
Current portion:
Received or receivable from Sanofi (see Note 4a)	$	15,927	$	12,815
Received or receivable from Bayer HealthCare (see Note 4b)	33,652		9,738
Received for technology license agreement (see Note 5)	23,572		23,572
Other	874		875
	$	74,025	$	47,000
Long-term portion:
Received or receivable from Sanofi (see Note 4a)	$	72,367	$	76,522
Received or receivable from Bayer HealthCare (see Note 4b)	46,486		26,683
Received for technology license agreement (see Note 5)	57,423		80,994
	$	176,276	$	184,199